- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 48
Daily Deal Round Up: September 14, 2021
Samsung-backed automation software developer Rezilion secured $30m while IGC Hospitality took part in restaurant management technology provider MarginEdge's $18m series B round.
Sep 14, 2021Forge Global hammers out $2bn reverse takeover
Deutsche Börse, Munich Re and Wells Fargo will secure exits through a deal that will give the private shares marketplace a public listing.
Sep 14, 2021Daily Deal Round Up: September 13, 2021
UPS is buying delivery service Roadie having helped it raise $62m while heart disease treatment developer Nectero Medical secured $19.5m in a Boston Scientific-led round.
Sep 13, 2021Exscientia explores Nasdaq IPO
Dundee spinout Exscientia has filed for an offering that would provide exits for SoftBank Vision Fund 2, Novo, BMS, Celgene, Evotec and Pivotal BioVenture Partners.
Sep 13, 2021Ximalaya descends from US offering
The Tencent-backed audio streaming platform developer cancelled its plans to float in New York after the Chinese authorities asked it to consider listing in Hong Kong.
Sep 13, 2021Exscientia explores Nasdaq IPO
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
Sep 13, 2021Analysis: PayPal pays $2.7bn to Paidy
PayPal is to purchase its portfolio company Paidy, a consumer finance service provider. Paidy is part of the wider payment tech space, which has seen an increasing number of exits since last year.
Sep 13, 2021Chronext prepares timing for $273m IPO
Mediengruppe Oberfranken and Tengelmann-backed luxury watch marketplace Chronext plans to float on the SIX Swiss Exchange later this year.
Sep 10, 2021Packable goes for $1.55bn reverse merger
Reckitt Benckiser, Emerson Group, McKesson and Sealed Air are set to score exits from the e-commerce services provider.
Sep 10, 2021Dice rolls on with IPO plans
Sanofi and Alexandria Real Estate Equities could exit the chronic disease therapeutics developer, which has set the range for an offering that could raise up to $170m.
Sep 10, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


